Content Type: Article

  • Exporting Craft Beer to Europe

    ARTICLE

    Exporting Craft Beer to Europe

    November/December 2016

    Read time: 2 min

    Key takeaways
    Overview

    Marc Sorini, Mélanie Bruneau, Stuart Mathews, Veronica Pinotti and Steffen Woitz wrote this bylined article on the regulatory challenges US craft brewers face to expand their market in Europe. Such brewers should “adapt distribution models that align with their commercial goals in order to take into account the European legal and regulatory context,” the authors wrote, especially as “each EU member state has its own regulatory and distribution peculiarities.”

    In depth
    Authors
    More insights

  • ECJ: No Liability of the Operator of Public WLAN Networks – Mc Fadden

    ARTICLE

    ECJ: No Liability of the Operator of Public WLAN Networks – Mc Fadden

    December 1, 2016

    Read time: 1 min

    Key takeaways
    Overview

     

    In depth
    Authors

    Dr. Claus Färber

    Counsel

    Munich

    More insights

  • The Chink in the Armor of CDA § 230

    ARTICLE

    The Chink in the Armor of CDA § 230

    December 2016

    Read time: 2 min

    Key takeaways
    Overview

    Banks Brown wrote this bylined article assessing how short-term rental companies like Airbnb use § 230 of the Communications Decency Act to argue that their online business is not subject to state and local regulation. Because “Congress did not want internet providers to be free of all regulation,” Mr. Banks wrote, a loss in court over § 230 protection could make STRCs “subject to the laws that govern all hotels, as well as the multitude of laws that govern all businesses in any given jurisdiction.”

    In depth
    Authors
    More insights

  • Estate of Play

    ARTICLE

    Estate of Play

    November 2016

    Read time: 2 min

    Key takeaways
    Overview

    Leigh-Alexandra Basha co-authored this bylined article on the impact of federal income taxes on US citizens and residents regarding their worldwide income and gifting. “Advising international clients with US connections requires an understanding of US federal tax rules,” the authors wrote. “The US system of worldwide taxation creates potential pitfalls for non-US citizen clients. Proper advance planning can successfully avoid unintended onerous tax exposure.”

    In depth
    Authors

    Leigh-Alexandra Basha

    Partner

    Washington, DC

    More insights

  • Guidance on Ransomware Attacks under HIPAA and State Data Breach Notification Laws

    ARTICLE

    Guidance on Ransomware Attacks under HIPAA and State Data Breach Notification Laws

    November/December 2016

    Read time: 2 min

    Key takeaways
    Overview

    Amy Gordon, Ann Killilea, Michael Morgan, Susan Nash, and Angela Stockbridge wrote this bylined article on new HIPAA guidance to covered entities and business associates on dealing with ransomware attacks. The guidance “establishes a floor for the security of electronic protected health information, although additional and/or more stringent security measures are certainly permissible and may be required under state law,” the authors wrote.

    In depth
    Authors

    Michael G. Morgan

    Partner

    Los Angeles, Silicon Valley

    More insights

  • Aerospace and Defense Series: Trump Administration—Potential for Increased Antitrust Leniency for Vertical Transactions in the Defense Industry

    Aerospace and Defense Series: Trump Administration—Potential for Increased Antitrust Leniency for Vertical Transactions in the Defense Industry

    ARTICLE / CLIENT ALERT

    Aerospace and Defense Series: Trump Administration—Potential for Increased Antitrust Leniency for Vertical Transactions in the Defense Industry

    November 30, 2016

    Read time: 8 min

    Key takeaways
    Overview

    President-elect Donald Trump has called for a dramatic increase in defense spending including purchases of new ships and warplanes as well as the addition of tens of thousands of new troops. This increase in spending generally bodes well for the aerospace and defense industry and potentially signals a new era of growth for companies in this space. This article examines how M&A transactions are likely to be reviewed in a Trump administration, with particular focus on “vertical” transactions.

    In depth

    A Trump administration is likely to create a more favorable environment for M&A in the aerospace and defense industry. President-elect Donald Trump has called for a dramatic increase in defense spending including purchases of new ships and warplanes as well as the addition of tens of thousands of new troops. This increase in spending generally bodes well for the aerospace and defense industry and potentially signals a new era of growth for companies in this space. Stock prices of aerospace and defense industry participants have seen significant increases with the S&P Aerospace & Defense index increasing more than nine percent in the two weeks following the US presidential election.

    The substantial growth in this sector may make it a target for M&A activity and raises the question of how a Trump administration will address antitrust concerns in defense industry transactions. President-elect Trump has not been outspoken about his potential antitrust policies and was unpredictable throughout his campaign. Therefore, we can only speculate as to how his administration will approach antitrust enforcement. Nonetheless, the entrance of a Republican administration and a presumably pro-defense, pro-business president suggests a more permissive antitrust policy for transactions in this sector.

    At the Margins, Expect Fewer Enforcement Actions and Less Focus on Vertical Theories under a Trump Administration

    Antitrust enforcement with respect to horizontal transactions—which combine two competitors at the same level of production—appears likely to remain stable. Past enforcement and the Horizontal Merger Guidelines make clear that transactions which combine two players with significant market share and will likely limit the number of potential bidders for upcoming procurements will continue to receive diligent review by the antitrust regulators with input from the US Department of Defense, which plays a vital role in the investigations of competition for future procurements. This theory of harm through horizontal concentration is a bedrock principle of antitrust enforcement that has been applied in Republican and Democratic administrations. Despite that consensus, at the margins, Democratic administrations tend to be more enforcement minded. At the end of the second Bush administration, for example, the US Department of Justice (DOJ) chose not to challenge several transactions which it seems very likely that the Obama DOJ would have challenged, such as Whirlpool / Maytag and XM / Sirius.

    On the other hand, it is likely that the Trump administration will reduce enforcement for vertical transactions. These are transactions that combine two players that do not compete against each other, but operate at different stages of production. Examples include a combination of a platform provider with a company that produces a payload used on that platform. Given the nature of the subcontracting and teaming relationships in the business, the aerospace and defense industry raises more vertical antitrust issues than most other industries. For this reason, a very high proportion of government challenges using vertical theories over the past several decades have involved transactions in the defense industry.

    While it is not unprecedented for Republican administrations to bring a case alleging vertical harm to competition, such as Northrop Grumman/TRW under the Bush administration, these transactions generally receive less scrutiny under Republican administrations. Therefore, this is one area where a Trump administration is likely to reach different enforcement decisions than an Obama administration. Keep in mind, however, that the staff at the Federal Trade Commission (FTC) and DOJ are not political appointees. This means that the same people will be investigating transactions under the Trump administration. The staff generally will investigate the same competitive issues under the Trump administration that it would have investigated under the Obama administration, which means that vertical theories will remain part of the antitrust review process. The biggest difference is likely to be at the leadership of the DOJ Antitrust Division and the FTC, where the “front office” leadership will switch from Democrat to Republican. Those leadership teams are less likely to authorize staff to challenge transactions raising more nuanced or novel issues, including vertical theories of harm. Thus, while investigations are not likely to be much different, we do expect to see differences in the ultimate enforcement decisions.

    Vertical Theories of Competitive Harm

    Even if vertical concerns are less likely to lead to a challenge under a Trump administration, they are still likely to be fully investigated. Therefore, it is important for businesses to understand exactly what vertical antitrust concerns are. Vertical analyses are often highly fact-specific, but there are several primary theories of competitive harm that the regulators will consider.

    Input Foreclosure

    Input foreclosure is the most straightforward vertical theory of anticompetitive harm. Input foreclosure arises when one company that provides a critical component or input (e.g., a payload) that is used by suppliers of a downstream product (e.g., an aircraft) combines with one of the downstream competitors. In this scenario, the transaction may provide the combined entity with the ability and incentive to deny, or raise the prices of, the key input to its downstream competitors and thereby reduce competition. In evaluating the competitive impacts of a transaction that presents a risk of input foreclosure, regulators will assess a number of factors to predict whether the company will have both the incentive and ability to deny the component to its rivals including:

    • The availability of a competitive substitute supplier of the input
    • Whether the downstream competitors can realistically turn to the alternative suppliers
    • Whether the combined entity has the opportunity to increase its sales of the downstream product if it withholds the necessary input from competitors
    • The relative revenues and profit margins available from the sale of the input component compared to the downstream product

    It should be noted that antitrust regulators are not just examining the current products and production relationships between the parties, but also reviewing a transaction’s impact on product innovation. The regulators are concerned that the combined entity may have the incentive to raise the costs of developing new products for other competitors or foreclose these competitors from a vital innovation partner going forward. Key factors in this analysis will include the existing relationships between various players in the industry and the viability of other competitors as potential innovation partners.

    Customer Foreclosure

    Customer foreclosure arises when a very large purchaser of an input combines with a supplier of that input. If the large purchaser directs all of its purchases to its in-house supplier of the input, that may leave insufficient business opportunities for competing upstream suppliers of the input to operate at an efficient scale, thus reducing competition at the input level. A key factor in this analysis will be the portion of the demand for the input that is likely to be foreclosed by the combination.

    Improper Information Exchanges

    Perhaps the most common vertical concern arises when a company in an M&A transaction possesses sensitive proprietary information of a competitor to the other M&A transaction party. The risk here is that post-transaction the combined entity will now pass the sensitive information in-house and improperly use it, leading to a reduction in competition.

    Substandard Products through Selection Bias

    The concern here arises when an acquisition leads a downstream product supplier, which does not face significant competition in the downstream market, to opt to use its newly acquired in-house input rather than a competing input even though the in-house solution is inferior. The concern is this type of selection can create a lower-quality or higher-priced good and harms consumers of the downstream product.

    Remedies for Vertical Transactions

    If a transaction raises vertical concerns, the regulators will want to ensure a remedy is implemented to prevent anticompetitive effects from arising. In vertical transactions, remedies have often involved “conduct remedies” rather than requiring divestiture of one of the vertically related businesses. Examples of conduct remedies are firewalls to prevent the misuse of competitively sensitive information, or non-discrimination provisions requiring a critical input supplier to support multiple competitors. However, while regulators have been willing to accept these conduct remedies in the past, parties cannot assume that conduct remedies will always be accepted in the future. A senior DOJ official recently stated “[s]ome vertical transactions may present sufficiently serious risks of foreclosing rivals’ access to critical inputs or customers, or otherwise threaten competitive harm, that they require some form of structural relief or even require that the transaction be blocked.”

    * * *

    Parties considering M&A transactions in the aerospace and defense industry should continue to evaluate the potential for vertical antitrust concerns and be prepared to defend their transactions. While the Trump administration may be less aggressive than the Obama administration, the staff at the antitrust agencies are likely to pursue the same theories, and parties need to be prepared to counter those theories.

    Authors

    Jon B. Dubrow

    Partner

    Washington, DC

    More insights

  • Code Sec. 956: Developments Concerning the 30-Day Exception

    ARTICLE

    Code Sec. 956: Developments Concerning the 30-Day Exception

    November/December 2016

    Read time: 2 min

    Key takeaways
    Overview

    Lowell Yoder wrote this bylined article on the 30-day Subpart F repayment exception covering loans to a related US person held by a controlled foreign corporation. “Temporary regulations have been issued that formally adopt the 30-day exception, although other developments make it more difficult to qualify for this exception,” Mr. Yoder wrote.

    In depth
    Authors

    Lowell D. Yoder

    Partner

    Chicago

    More insights

  • Bipartisan Legislation Proposes Telehealth Solutions for Effective Chronic Disease Management

    Bipartisan Legislation Proposes Telehealth Solutions for Effective Chronic Disease Management

    ARTICLE / CLIENT ALERT

    Bipartisan Legislation Proposes Telehealth Solutions for Effective Chronic Disease Management

    November 28, 2016

    Read time: 7 min

    Key takeaways
    Overview

    Collaborative efforts between congressional offices and various health care stakeholders, as well as the feedback provided in response to the Bipartisan CHRONIC Care Working Group Policy Options Document released in December of 2015, have driven the Senate Finance Committee to introduce a draft of bipartisan legislation known as the CHRONIC Care Act, which seeks to modernize Medicare payment policies to improve the management and treatment of chronic diseases using telehealth.

    In depth

    As a result of the collaborative efforts between congressional offices and various health care stakeholders, and the feedback provided in response to the Bipartisan CHRONIC Care Working Group Policy Options Document released in December of 2015, the Senate Finance Committee recently introduced a draft of bipartisan legislation known as the Creating High-Quality Results and Outcomes necessary to Improve CHRONIC Care Act of 2016 (the CHRONIC Care Act). The CHRONIC Care Act seeks to modernize Medicare payment policies to improve the management and treatment of chronic diseases using telehealth.

    Over the past several years, there has been increased attention by Congress and federal agencies on prevention, management and treatment of chronic conditions, such as cancer, heart disease, obesity and diabetes, as they are long-lasting and persistent health problems that require continuous, expensive care. Studies conducted by federal agencies have shown that patients with multiple chronic conditions can cost up to seven times as much as patients with only one chronic condition and chronic diseases are responsible for more than 75 percent of the trillions of dollars spent annually on health care. The CHRONIC Care Act aims to deliver higher quality care to Medicare beneficiaries with one or more chronic conditions and reduce the costs associated with the provision of such care through the use of telehealth.

    Below is a summary of the key telehealth provisions under the CHRONIC Care Act that aim to expand access to home dialysis therapy and timely stroke care, increase convenience for Medical Advantage enrollees, and improve care coordination by accountable care organizations (ACO).

    Expanding Access to Home Dialysis Therapy

    Currently, Medicare covers and reimburses dialysis therapy provided to Medicare beneficiaries if certain requirements are met, including the provision of the service at an authorized originating site (including a physician office and hospital-based dialysis facility) that is located in a rural Health Professional Shortage Area (HPSA) or area outside a Metropolitan Statistical Area (MSA). The CHRONIC Care Act proposes to allow beneficiaries that receive dialysis to receive required monthly clinical assessments to monitor their condition using telehealth without geographic restriction beginning in 2018. Specifically, the CHRONIC Care Act would expand the originating sites from which the beneficiary can choose to receive an assessment via telehealth to include freestanding dialysis facilities and, importantly, the patient’s home.

    Increasing Convenience for Medicare Advantage Enrollees through Telehealth

    Medicare pays for a limited number of Part B services furnished by a physician or practitioner to an eligible beneficiary via a telecommunications system (i.e., interactive audio and video telecommunications system that permits real-time communication between the practitioner at the distant site and the Medicare beneficiary at the originating site). Reimbursement for these telehealth services includes payments to physicians or other professionals (at the distant site) for the telehealth consultation, and to the facility where the patient is located (the originating site). A Medicare Advantage plan may provide telehealth services to its beneficiaries, including, but not limited to, using telemonitoring and web-based and phone technologies, and providing medication therapy management via telehealth; however, any telehealth services beyond what is covered under Medicare must be paid for through the Medicare Advantage plan’s rebate dollars as a supplemental benefit.

    The CHRONIC Care Act proposes to allow a Medicare Advantage plan to offer additional, clinically appropriate, telehealth services as a part of its benefits to beneficiaries in its annual bid amount. A Medicare Advantage beneficiary would have the ability to decide whether or not to receive services via telehealth. Further, including telehealth services and technologies to the package of benefits would not change the requirement that Medicare Advantage plans meet network adequacy requirements.

    Providing Accountable Care Organizations (ACOs) the Ability to Expand Use of Telehealth

    In recognition that telehealth may be a tool to increase access to care and drive down health care costs, the CHRONIC Care Act proposes to eliminate some of the restrictions on reimbursement for telehealth services for ACOs. Specifically, the CHRONIC Care Act would (1) allow beneficiaries assigned to an ACO under the Medicare shared Savings Program (MSSP) to receive currently allowable telehealth services in the patient’s home, (2) eliminate the geographic component of the originating site requirement, and (3) allow providers to furnish telehealth services as currently specified under Medicare’s physician fee schedule, with limited exceptions. Reimbursement under Medicare would be contingent upon the telehealth services being delivered to a beneficiary at an approved originating site, such as a hospital, or at the beneficiary’s place of residence. Not surprisingly, the CHRONIC Care Act does not propose that Medicare provide a separate payment for the originating site fee if the service is furnished in the patient’s home.

    Notwithstanding, the election of President-elect Donald Trump and Republican majorities in both the House of Representatives and Senate creates uncertainty regarding the MSSP due to threats of repealing or drastically overhauling the Affordable Care Act.

    Expanding Use of Telehealth for Individuals with Stroke

    Currently, Medicare pays for physician services related to stroke treatment under the Physician Fee Schedule, the Hospital Outpatient Prospective Payment System and Inpatient Prospective Payment System. In addition to the physician services furnished when a beneficiary presents symptoms of stroke at the hospital emergency department, Medicare will pay a physician for consulting on a patient experiencing acute stroke symptoms via telehealth (at a distant site) if the hospital where the beneficiary presents (the originating site) is in a HPSA, or a county outside a MSA.

    The CHRONIC Care Act proposes to expand the ability of patients presenting with stroke symptoms to receive a consultation via telehealth, beginning in 2018. Specifically, the CHRONIC Care Act would eliminate the geographic restriction on reimbursement for tele-stroke services to permit payment to physicians furnishing the telehealth consultation service in all areas of the country. However, the CHRONIC Care Act does not propose that the hospital at which the patient is present and the telehealth consultation is initiated receive a separate originating site payment.

    The CHRONIC Care Act is yet another piece of legislation aimed at expanding Medicare coverage for telehealth services for certain types of beneficiaries, signaling an increased recognition by Congress of its ability to lower the costs of health care delivery and improve patient health. Other legislation that has taken on this challenge includes the Creating Opportunities Now for Necessary and Effective Care Technologies for Health Act (S. 2484 and H.R. 4442). We anticipate the proposal of additional legislation focused on expanding coverage for telehealth services in 2017 (and beyond).

    Authors

    Lisa Mazur

    Partner

    Chicago

    More insights

  • Mergers and Acquisitions: 15 Important Considerations for In-House Counsel

    ARTICLE

    Mergers and Acquisitions: 15 Important Considerations for In-House Counsel

    November 27, 2016

    Read time: 2 min

    Key takeaways
    Overview

    David Lipkin was co-author of this bylined article on the key strategic, negotiating and diligence considerations involved in the typical sale of a privately held company, and the steps that the company’s in-house counsel can take to better understand, prepare for and address these considerations for “ensuring that a smooth and successful sale can occur.”

    In depth
    Authors

    David A. Lipkin

    Counsel

    Silicon Valley

    More insights

  • Affordable Wet Lab Space Critical To Nurturing Early-Stage Biopharma

    ARTICLE

    Affordable Wet Lab Space Critical To Nurturing Early-Stage Biopharma

    November 27, 2016

    Read time: 2 min

    Key takeaways
    Overview

    Richard Smith wrote this bylined article on how early-stage biopharma companies in the Boston area have secured affordable business space through shared biopharma wet lab facilities where multiple early-stage companies share equipment and specialized facilities, as well as access to technical and administrative resources.

    In depth
    Authors

    Richard B. Smith

    Counsel

    Boston

    More insights